3 ms·
A few thousand vs 100’s of millions of fat Americans who could beneficially use this? That hardly seems fair.
by EasyMark 2y ago
A few thousand vs 100’s of millions of fat Americans who could beneficially use this? That hardly seems fair.
- lotsofpulp 2y agoStockholders are global, there is no disproportionate gain for Europeans. Novo trades on an American stock market, and Americans (whoever they may be) are reaping just as much of a benefit from Novo as they would from Eli/Pfizer/etc.